Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  16 (2024)
Volume  15 (2023)
Volume  14 (2022)
Volume  13 (2021)
Volume  12 (2020)
Volume  11 (2019)
Volume  10 (2018)
Volume  9 (2017)
Volume  8 (2016)
Volume  7 (2015)
Volume  6 (2014)
Volume  5 (2013)
Volume  4 (2012)
Volume  3 (2011)
Volume  2 (2010)
Volume  1 (2009)
Related articles

VOLUME 16 , ISSUE 2 ( March-April, 2024 ) > List of Articles

REVIEW ARTICLE

Inclusion of Pregnant Women in Clinical Trials: Need, Ethical and Scientific Considerations and Current Status

Hanif Shaikh, Priyanka V Mahadik, Parveen Shaikh, Anil Pardeshi, Shravani P Wakte, Krishna S Dakh, Mahesh Asalkar, Vaishali R Undale, Anand S Kawade, Chandrashekhar Upasani

Keywords : Clinical trials, Current status, Ethical considerations, Pregnant women, Scientific consideration

Citation Information : Shaikh H, Mahadik PV, Shaikh P, Pardeshi A, Wakte SP, Dakh KS, Asalkar M, Undale VR, Kawade AS, Upasani C. Inclusion of Pregnant Women in Clinical Trials: Need, Ethical and Scientific Considerations and Current Status. J South Asian Feder Obs Gynae 2024; 16 (2):126-133.

DOI: 10.5005/jp-journals-10006-2401

License: CC BY-NC 4.0

Published Online: 23-02-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

This article summarizes all aspects related to the exclusion and inclusion of pregnant women in clinical trials. Historically to date, pregnant women were observed as most excluded population from clinical research. There are various scientific as well as ethical reasons behind their exclusion. However, given the burden of various illnesses and diseases during pregnancy, there is a need to include them in clinical research. Available data regarding safety and efficacy of medicinal products were also collected from accidental exposure. But these evidences are insufficient to give results. Various ethical aspects and scientific reasons are also given proper evidences to include pregnant women in clinical trials. In this review, we have summarized data from clinicaltrials.gov.in on completed clinical trials exclusively on pregnant women and ongoing clinical trials in pregnant women to find out the current status of pregnant women in clinical research. There is a need to consider designing of clinical trials in pregnant women in such a way that fear of any harm should be overcome, such that more pregnant women can participate in clinical trials.

HTML PDF Share
  1. Clinical trials [Internet]. [cited 2021 Sep 30]. Available from: https://www.who.int/health-topics/clinical-trials#tab=tab_1.
  2. US Food and Drug Administration. Public workshop: Evaluating inclusion and exclusion criteria in clinical trials. 2018. Available from: https://www.fda.gov/media/134754/download.
  3. van Der Zande ISE, van Der Graaf R, Oudijk MA, et al. Vulnerability of pregnant women in clinical research. J Med Ethics 2017;0:1–7.
  4. FDA, CDER. Postapproval Pregnancy Safety Studies Guidance for Industry. Draft Guidance. [cited 2021 Oct 25]; Available from: https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm.
  5. Subpart B - Additional Protections for Pregnant Women, Human | HHS.gov [Internet]. [cited 2022 Apr 22]. Available from: https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/common-rule-subpart-b/index.html#46.204.
  6. Lori A, Colleen MG. Pregnancy and protection: The ethics of limiting a pregnant woman's participation in clinical trials. J Clin Res Bioeth 2011;2(108):1000108. DOI: 10.4172/2155-9627.1000108.
  7. Roes KCB, van der Zande IS, van Smeden M, et al. Towards an appropriate framework to facilitate responsible inclusion of pregnant women in drug development programs. Trials 2018;19(1):123. DOI: 10.1186/s13063-018-2495-9.
  8. World Health Organization. Facts and figures from World health organization. 2005;1–6. Available from: http://www.who.int/whr/2005/media_centre/facts_en.pdf.
  9. Maternal health | UNICEF India [Internet]. [cited 2021 Oct 13]. Available from: https://www.unicef.org/india/what-we-do/maternal-health.
  10. Pregnancy mortality surveillance system | Maternal and Infant Health | CDC [Internet]. [cited 2021 Nov 28]. Available from: https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm#causes.
  11. Maternal mortality [Internet]. [cited 2021 Nov 26]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/maternal-mortality.
  12. Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med 2014;370(23):2211–2218. DOI: 10.1056/NEJMra1213566.
  13. Feghali M, Venkataramanan R, Caritis S, et al. Pharmacokinetics of drugs in pregnancy Maisa. Semin Perinatol 2016;39(7):512–519. DOI: 10.1053/j.semperi.2015.08.003.
  14. Momper JD, Best BM, Wang J, et al. Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV. AIDS 2018;32(17):2507–2516. DOI: 10.1097/QAD.0000000000001992.
  15. Anger GJ. Pharmacokinetic studies in pregnant women. Clin Pharmacol Ther 2008;83(1). DOI: 10.1038/sj.clpt.6100377.
  16. Hans-Joachim T. Cardiac arrhythmias in the pregnant woman and the foetus. Eur Cardiol Rev 2008;4(2):67–71. DOI: https://doi.org/10.15420/ecr.2008.4.2.67.
  17. Guidance for Industry. Pharmacokinetics in pregnancy — Study design, data analysis, and impact on dosing and labeling. 2004.
  18. Mckiever M, Frey H, Costantine MM, et al. Challenges in conducting clinical research studies in pregnant women. J Pharmacokinet Pharmacodyn 2021;47(4):287–293. DOI: 10.1007/s10928-020-09687-z.
  19. Committee Opinion No. 646. Obstet Gynecol [Internet]. 2015 Nov [cited 2022;126(5):e100–7. Available from: https://journals.lww.com/greenjournal/Fulltext/2015/11000/Committee_Opinion_No__646__Ethical_Considerations.54.aspx.
  20. Food and Drug Administration. Pregnant women: Scientific and ethical considerations for inclusion in clinical trials guidance for industry. 2018;4:1–14. Available from: https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm%0Ahttp://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm.
  21. Payne P. Including pregnant women in clinical research: Ethics Hum Res 2019;41(6):35–40. DOI: 10.1002/eahr.500036.
  22. List of recommendations from the task force on research specific to pregnant women and lactating women (PRGLAC) | NICHD - Eunice Kennedy Shriver National Institute of Child Health and Human Development [Internet]. [cited 2022 Aug 21]. Available from: https://www.nichd.nih.gov/about/advisory/PRGLAC/recommendations.
  23. Pfizer-BioNTech. Pfizer-Biontech Covid-19 vaccine (Bnt162, Pf-07302048) vaccines and related biological products advisory committee briefing document. 2020;23(December):92. Available from: https://www.fda.gov/media/144246/download.
  24. Chaudhry S, Sovani V. Research conducted on gestating women globally during trials. Indian J Pharm Pharmacol 2022;8(4):301–314.
  25. Immunogenicity and safety of an inactivated non-adjuvanted A(H1N1)v influenza vaccine in pregnant women. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT01024400.
  26. Primary breast cancer occurring concomitant with pregnancy. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT00510367.
  27. The effects of metformin on pregnancy and miscarriage rates in polycystic ovary syndrome (PCOS). ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT00994812.
  28. Study of rubella immunity. Response to vaccination of subjects with very low, equivocal or undetectable titers of rubella virus antibodies. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT02934295.
  29. Valacyclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT02351102.
  30. A phase I study of the safety and pharmacokinetics of recombinant CD4 immunoglobulin G (rCD4-IgG) in HIV-1 seropositive women during the last trimester of pregnancy and their newborns. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT00000642.
  31. Fortovase (Saquinavir) given with low-dose ritonavir, zidovudine, and lamivudine to HIV-positive pregnant women during and after pregnancy and to their newborns. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT00000920.
  32. Safety of VIRACEPT® 625 mg administered to HIV-infected women during pregnancy. Full text view - ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT00246610.
  33. A phase I study of safety and pharmacokinetics of nevirapine in HIV-1 infected pregnant women and neonates born to HIV-1 infected mothers. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://www.clinicaltrials.gov/ct2/show/results/NCT00000808?view=results.
  34. Methotrexate treatment for ectopic pregnancy. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT01855568.
  35. The efficacy of Diclectin® for nausea and vomiting of pregnancy. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT00614445.
  36. Metformin in obese non-diabetic pregnant women. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT01273584.
  37. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT01576458.
  38. Prevention of Hepatitis B virus vertical transmission by serovaccination and tenofovir during pregnancy. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT02039362.
  39. Pravastatin for prevention of preeclampsia. ClinicalTrials.gov [Internet]. [cited 2022 May 8]. Available from: https://clinicaltrials.gov/ct2/show/study/NCT01717586.
  40. Safety, pharmacokinetics and efficacy of an AT-III concentrate. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT00319228.
  41. Antiviral prophylaxis and infant vaccination to prevent perinatal Hepatitis B infection. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT03343431.
  42. Hydrocortisone for BPD. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://www.clinicaltrials.gov/ct2/show/NCT01353313.
  43. Medical optimization of management of type 2 diabetes complicating pregnancy (MOMPOD). ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT02932475.
  44. A novel regimen to prevent Malaria and STI in pregnant women with HIV (Premise). ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT03431168.
  45. Randomised trial of 3 artemisinin combination therapy for Malaria in pregnancy (DMA) ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT01054248.
  46. Safety, immunogenicity, and protective efficacy of radiation attenuated plasmodium falciparum NF54 Sporozoites (PfSPZ Vaccine) during malaria transmission season in Healthy African adult women of childbearing potential in Mali. ClinicalTrials.gov [Internet]. [cited 2022 May 11]. Available from: https://clinicaltrials.gov/ct2/show/NCT03989102.
  47. Sheffield JS, Siegel D, Mirochnick M, et al. Designing drug trials: Considerations for pregnant women. Clin Infect Dis 2014;59(2): S437–S444. DOI: 10.1093/cid/ciu709.
  48. Stock SJE, Norman JE. Medicines in pregnancy. F1000Res 2019;8:1–8. DOI: 10.12688/f1000research.17535.1.
  49. Baylis F, Halperin SA. Research involving pregnant women: Trials and tribulations. Clin Trial Perspect 2012;2(2):139–146. Available from: www.future-science.com.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.